Catto, J., Hartmann, A., Stoehr, R., Bolderson, E., Rehman, I., Rosario, D., . . . Meuth, M. (2006). Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
Chicago Style (17th ed.) CitationCatto, J., A. Hartmann, R. Stoehr, E. Bolderson, I. Rehman, D. Rosario, F. Hamdy, and M. Meuth. Multifocal Urothelial Cancers with the Mutator Phenotype Are of Monoclonal Origin and Require Panurothelial Treatment for Tumor Clearance. 2006.
MLA (9th ed.) CitationCatto, J., et al. Multifocal Urothelial Cancers with the Mutator Phenotype Are of Monoclonal Origin and Require Panurothelial Treatment for Tumor Clearance. 2006.
Warning: These citations may not always be 100% accurate.